Advanced search
Publication Cover
Journal of Inflammation Research Volume 14, 2021 - Issue
Submit an article Journal homepage
71
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Multiple Cytokines Elevated in Patients with Keloids: Is It an Indication of Auto-Inflammatory Disease?

Ferdinand W Nangole1 Department of Surgery, University of Nairobi, Nairobi, KenyaCorrespondence[email protected]
View further author information
,
Kelsey Ouyang2 Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, California, USAView further author information
,
Omu Anzala3 Institute of Aids Vaccine Initiative, University of Nairobi, Nairobi, KenyaView further author information
,
Julius Ogengo4 Department of Human Anatomy, University of Nairobi, Nairobi, KenyaView further author information
&
George W Agak2 Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, California, USAView further author information
Pages 2465-2470 | Published online: 10 Jun 2021

References

  • Jumper N, Raus R, Bayat A. Functional histopathology of Keloid disease. Histo-Pathol. 2015;1033–1057.
  • Chike-Obi CJ, Cole PD, Brissett AE. Keloids: pathogenesis, clinical features, and management. Semin Plast Surg. 2009;23(3):178–184. doi:10.1055/s-0029-1224797
  • Ogawa R. Keloid and Hypertrophic Scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):606. doi:10.3390/ijms18030606
  • Nangole FW, Agak W. Keloid pathophysiology: fibroblast or inflammatory disorders? JPRAS Open. 2019;22:44–54. doi:10.1016/j.jpra.2019.09.004
  • Ali MM, Karanja FW, Nang’ole FW, Opot EON, Mulehane KO, Mbithi DZ. Determination of the prevalence, clinical characteristics and histo-pathological features of keloids in patients managed at the Kenyatta National Hospital. East Afri Med J. 2019;96(1):2220–2229.
  • Hajdarbegovic E, Bloem A, Balak D, Thio B, Nijsten T. The association between atopic disorders and keloids: a Case-control Study. Indian J Dermatol. 2015;60(6):635–639. doi:10.4103/0019-5154.169144
  • Ying-Yi L, Chun-Ching L, Yu W-W. Keloid risk in patients with atopic dermatitis: a nationwide retrospective cohort study in Taiwan. BMJ Open. 2018;89–97.
  • Jagajeevan J, Bayat A. Transforming growth factor B and keloid disease. Int J Surg. 2007;5:278–285. doi:10.1016/j.ijsu.2006.04.007
  • Liu Y, Yue L. Transforming Growth factor Beta 1, promote scar fibroblasts proliferation and trans differentiation via upregulating micro rna −21. Sci Rep. 2016. doi:10.1038/srep32231
  • Oliver B, Haiyan YU. Studies of TGFB1 –B3 and their receptors 1 and 2 in fibroblasts of keloids and hypertrophic scars. Arch Dermat Venereal. 2005;85:216–220.
  • Robert LM, Chopra V. Altered cytokines production in Black patients with keloids. J Clin Immunol. 2012;12:300–308.
  • Zhang Q, Yamaza T, Kelly AP. Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 Axis. PLOS. 2009;4(11):e7798. doi:10.1371/journal.pone.0007798
  • Ghazizadeh M, Tosa M. Functional implications of IL-6 signalling pathways in keloid pathogenesis. J Invest Dermatol. 2007;127:98–105. doi:10.1038/sj.jid.5700564
  • Huixue. H, McCauley RL, Zhang W. Elevated interleukin −6 expression in keloid fibroblasts. J Surg Res. 2000;89(1):74–77.
  • Luo L, Li J, Wu Y, Qiao J, Fang H. Adiponectin, but Not TGF-β1, CTGF, IL-6 or TNF-α, May be a potential anti-inflammation and anti-fibrosis factor in keloid. J Inflamm Res. 2021;14:907–916. PMID: 33758530. PMCID:PMC7981148. doi:10.2147/JIR.S301971
  • Nézondet A-L, Poubelle E, Pelletier PM. The evaluation of cytokines to help establish diagnosis and guide treatment of auto-inflammatory and autoimmune diseases. J Leukoc Biol. 2020;108:647–657. doi:10.1002/JLB.5MR0120-218RRR
  • de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined auto-inflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol. 2015;33:823–874. doi:10.1146/annurev-immunol-032414-112227
  • Ciccarelli F, De Martinis M, Ginaldi*An L. Update on auto-inflammatory diseases. Curr Med Chem. 2013;21(3):261–269. doi:10.2174/09298673113206660303
  • Hirano T. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(7):717–730. doi:10.2183/pjab.86.717
  • Xu H, Xiao X, He Y. Increased serum interleukin-6 levels in patients with hidradenitis suppurativa. Postepy Dermatol Alergol. 2017;34(1):82–84. doi:10.5114/ada.2017.65626
  • Galeotti C, Boucheron A, Guillaume S, Koné-Paut I. Sustained remission of multicentric castleman disease in children treated with tocilizumab. Pediatr Rheumatol Online J. 2011;9(Suppl 1):P6–9. doi:10.1186/1546-0096-9-S1-P6
  • Steinke JW, BorishTh L. cytokines and asthma — interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2001;2(2):66–70.
  • Brucato A, Emmi G, Cantarini L, et al. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med. 2018;13:475–489. doi:10.1007/s11739-018-1842-x
  • Diaz A, Tan K, He H, Xu H, Cueto I. Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy. J Eur Acad Dermatol Venereol. 2020;34(4):e161–e164. doi:10.1111/jdv.16097
  • da Silva IR, Tiveron LCRDC, da Silva MV, et al. In situ cytokine expression and morphometric evaluation of total collagen and collagens. Mediators Inflamm. 2017. doi:10.1155/2017/6573802

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.